Inpharma Weekly

, Volume 1206, Issue 1, pp 11–12 | Cite as

Venlafaxine keeps the blues away

  • Carmen Innes
Newsletter Article

Abstract

Wyeth-Ayerst’s venlafaxine [‘Effexor’] appears to provide better remission rates in patients with depression compared with selective serotonin reuptake inhibitors (SSRIs). These results, from a meta-analysis of 8 clinical studies, were presented at the 11th World Congress of Psychiatry [ Hamburg, Germany; August 1999 ]. Also presented were trials showing that venlafaxine improves cognition in elderly patients with depression compared with dothiepin, and that extended-release (XR) venlafaxine is effective in preventing relapse in patients with depression.

Keywords

Venlafaxine Major Depressive Disorder 11th World Relapse Prevention Dothiepin 

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Carmen Innes

There are no affiliations available

Personalised recommendations